Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics Journal Article


Authors: Scher, H. I.; Nasso, S. F.; Rubin, E. H.; Simon, R.
Article Title: Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics
Abstract: A critical challenge in the development of new molecularly targeted anticancer drugs is the identification of predictive biomarkers and the concurrent development of diagnostics for these biomarkers. Developing matched diagnostics and therapeutics will require new clinical trial designs and methods of data analysis. The use of adaptive design in phase III trials may offer new opportunities for matched diagnosis and treatment because the size of the trial can allow for subpopulation analysis. We present an adaptive phase III trial design that can identify a suitable target population during the early course of the trial, enabling the efficacy of an experimental therapeutic to be evaluated within the target population as a later part of the same trial. The use of such an adaptive approach to clinical trial design has the potential to greatly improve the field of oncology and facilitate the development of personalized medicine. ©2011 AACR.
Journal Title: Clinical Cancer Research
Volume: 17
Issue: 21
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2011-11-01
Start Page: 6634
End Page: 6640
Language: English
DOI: 10.1158/1078-0432.ccr-11-1105
PROVIDER: scopus
PUBMED: 22046024
PMCID: PMC3853353
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 9 December 2011" - "CODEN: CCREF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard Scher
    1130 Scher